• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » GSK expands Australian facility, creates 58 jobs

GSK expands Australian facility, creates 58 jobs

February 10, 2012
CenterWatch Staff

GlaxoSmithKline (GSK) is investing roughly $64 million to expand its manufacturing and drug development activities in its Boronia facility near Melbourne, Australia.

The Boronia facility, which serves as GSK’s Australia headquarters, is the company’s largest sterile manufacturing facility, featuring eight filling machines, six packaging lines and state-of-the-art “blow-fill-seal” (BFS) technology. 

The project is expected to create 58 new “highly-skilled” jobs by 2017, double GSK’s BFS manufacturing capacity—which it would make available to local companies—and fund the creation of a pilot scale industrialization facility for new power and sterile liquid pharmaceuticals.

“This investment will build a sustainable manufacturing capability within the local community while driving manufacturing technology,” said site director Troy Webb.

The Boronia facility will continue to support GSK’s R&D collaboration with Monash Institute of Pharmaceutical Sciences to develop next-generation drugs.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing